Uncategorized Archives - Page 24 of 251

ThursdayMay 04, 2023 9:00 am

NECANN Connecticut Cannabis & Hemp Convention to Deep Dive Into the Rapidly Changing Cannabis Industry

The 2023 Connecticut Cannabis & Hemp Convention is being held at one of the most prestigious locations in Connecticut, the XL Center, 1 Civic Center Plaza in Hartford, CT on May 20-21, 2023. NECANN takes note of reputable brands, as well as creative entrepreneurs on the scene, to create a vibrant blend of exhibitors, speakers, and panelists, that keep attendees engaged and inspire repeat visits to events. The convention attracts industry-leading professionals who will present the latest insights into the cannabis industry. With expert speakers and exhibitors, the convention will have it all: science, cultivation, new opportunities, legal, branding, business…

WednesdayMay 03, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX), Featured in Recent Research Report by Zacks SCR

Zacks recently released a research report covering Lexaria Bioscience, a global innovator in drug delivery platforms The report discusses the company’s ongoing research and development (“R&D”) programs, forecasting penetration into global markets for hypertension, oral nicotine delivery, and antiviral product categories Lexaria is targeting conditions with significant market potential, including hypertension, diabetes, dementia, and seizures These programs position the company for entry into collaborative opportunities to support further growth and provide growth capital Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, featured in a recently released research report from Zacks Small-Cap Research (“SCR”) (https://cnw.fm/R891E). The report considers…

FridayApr 28, 2023 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Successful DIAB-A22-1 Diabetes Study Indicates Just One of Several Potential Applications for DehydraTECH(TM) Drug Delivery Platform Technology

Lexaria recently completed its diabetes animal model study, DIAB-A22-1, an ambitious study that explored the potential of its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for the treatment of diabetes The study showed at least three primary positive outcomes, including weight loss and improved triglyceride and cholesterol levels, with lower doses of DehydraTECH-CBD achieving the most optimum outcome The success of this study inches Lexaria closer to capitalizing on the potential of the diabetes drug market, estimated at $63.1 billion in 2021 It also points to the technology’s effectiveness, particularly following the success of the company’s most ambitious clinical study, HYPER-H21-4, demonstrating the…

ThursdayApr 27, 2023 10:30 am

Lift Toronto 2023 Promises to Drive Meaningful Change and Sustainable Growth in Cannabis Industry while Providing Memorable Experiences

Lift Events & Experiences, a collective known for organizing Canada’s number-one cannabis industry conferences and trade shows, invites cannabis retailers, licensed producers, growers, budtenders, brands, investors, and everyday folks, for the Lift Toronto 2023 event scheduled for June 1-3, 2023 at the Metro Toronto Convention Centre (“MTCC”). The three-day action-packed convention is set to continue a tradition that has become synonymous with each of Lift Events & Experiences’ events: showcasing leading-edge content and premier exhibitors in a high-energy, unique setting. The first day of the event will play host to the Lift Cannabis Business Conference, Canada’s premiere business strategy gathering…

TuesdayApr 18, 2023 4:20 am

420 with CNW — Arkansas Legislators Send Bill on Medical Cannabis Patients’ Gun Rights to Governor

A measure allowing medical marijuana users to receive concealed carry permits for weapons has been approved by the Arkansas Senate. Representative Aaron Pilkington introduced the bill, which was approved by the House of Representatives last Tuesday prior to being approved by the entire Senate on Friday. According to the proposed legislation, a person's eligibility for medical marijuana cannot be utilized to decide whether they are qualified for a firearms license. A person who participates in the medical cannabis protocol does not become a chronic or persistent user of a prohibited substance, which may prevent them from receiving concealed-carry approval, according…

MondayApr 17, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes the Licensed Use of its DehydraTECH(TM) Technology to Complement its Royalty Earnings and Realize Revenue in Advance of Royalties

Chris Bunka, Lexaria’s CEO, has reiterated the company’s commitment to creating value for its shareholders with the licensed use of its patented DehydraTECH(TM) technology Mr. Bunka has noted that Lexaria is already in discussions with interested parties in Europe and North America, a move that presents a critical fiscal opportunity for the company He has emphasized how profitable new licensing agreements could be for the company, presenting additional avenues for Lexaria to generate revenue and create value for its shareholders As the company continues to make a transition toward a more commercial focus in 2023, Bunka notes that licensing will…

WednesdayApr 12, 2023 9:45 am

Lift Toronto 2023 Cannabis Conference and Expo Announces Speakers and Sessions; Registration Now Open

Thousands of cannabis industry and community members will gather at the Metro Toronto Convention Centre, June 1-3, for three high-energy days of discovery, education, entertainment and more. The highly anticipated Lift Toronto 2023 Cannabis Conference and Expo, which will bring together thousands of cannabis industry professionals and consumers from all parts of the cannabis ecosystem, returns to the Metro Toronto Convention Centre from June 1-3, 2023. Hundreds of exhibiting companies will showcase the latest in cannabis products, services and innovations; industry leaders and fresh voices will take the stage; and new experiences and activations will lead to Lift’s signature a-ha…

MondayApr 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Revolutionizing Drug Delivery Potential for Active Pharmaceutical Ingredients Using Patented DehydraTECH(TM) Technology

DehydraTECH(TM)-enabled drugs and product formats improve the speed of onset, increase bioavailability, increase brain absorption, enhance drug potency, reduce drug administration costs, and mask unwanted tastes, shown effective with a growing number of medical applications Current DehydraTECH studies (animal and human) include hypertension, dementia, oral nicotine, epilepsy, and diabetes Most recently, Lexaria’s DehydraTECH-CBD studies for hypertension have produced positive results, and the company is seeking IND status with the FDA Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed a disruptive drug delivery technology with multiple opportunities for success in cannabinoids, oral nicotine and other active…

WednesdayApr 05, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Multiple Commercial Applications for Its Patented DehydraTECH(TM) Technology Platform

Lexaria Bioscience, a global innovator in drug delivery platforms, has developed and patented the DehydraTECH(TM) drug delivery platform technology The company has undertaken multiple studies as part of its extensive R&D program involving DehydraTECH, which continues to yield positive results This R&D program is focused on the development of product candidates across four main segments, which represent the platform’s potential commercial applications These segments include the development of DehydraTECH-processed cannabidiol (“CBD”) for hypertension, epilepsy, diabetes and dementia; DehydraTECH-processed oral nicotine; other pharmaceutical areas exploring a wide range of DehydraTECH-processed active molecules; and hemp-derived CBD applications for consumer packaged goods (“CPG”)…

MondayApr 03, 2023 11:15 am

Prime Harvest Inc. Launches Weed 4 The People Reg A+ Offering to Fund Cannabis Retail and Delivery Expansion Across California

Prime Harvest launched Reg A+ offering, Weed 4 The People, which enables public to invest for as little as $4.20 per share Company aims to raise $42M to fund expansion of JAXX Cannabis, flagship store and delivery platform Company achievements include 976% revenue growth from 2019-2022, 395% unique customer growth, 60+ brand partners Company aims to open 20++ locations across California within five years, recently received approval recommendation for conditional use permit to open retail cannabis outlet in the City of San Diego Prime Harvest, a tech-focused legal cannabis enterprise and parent company to SoCal’s premier dispensary JAXX Cannabis, recently…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized